These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3284301)

  • 1. Psychotropic effects of caffeine.
    Clementz GL; Dailey JW
    Am Fam Physician; 1988 May; 37(5):167-72. PubMed ID: 3284301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses.
    Hewlett P; Smith A
    Hum Psychopharmacol; 2007 Aug; 22(6):339-50. PubMed ID: 17514640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine consumption and anxiety and depressive symptomatology among medical students.
    Mino Y; Yasuda N; Fujimura T; Ohara H
    Arukoru Kenkyuto Yakubutsu Ison; 1990 Dec; 25(6):486-96. PubMed ID: 2085289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test.
    Nardi AE; Lopes FL; Freire RC; Veras AB; Nascimento I; Valença AM; de-Melo-Neto VL; Soares-Filho GL; King AL; Araújo DM; Mezzasalma MA; Rassi A; Zin WA
    Psychiatry Res; 2009 Sep; 169(2):149-53. PubMed ID: 19698996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal syndrome after the double-blind cessation of caffeine consumption.
    Silverman K; Evans SM; Strain EC; Griffiths RR
    N Engl J Med; 1992 Oct; 327(16):1109-14. PubMed ID: 1528206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic manifestations of caffeinism.
    Victor BS; Lubetsky M; Greden JF
    J Clin Psychiatry; 1981 May; 42(5):185-8. PubMed ID: 7217021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose caffeine physical dependence in humans.
    Griffiths RR; Evans SM; Heishman SJ; Preston KL; Sannerud CA; Wolf B; Woodson PP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1123-32. PubMed ID: 2262896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine: a potential drug of abuse.
    Gilliland K; Bullock W
    Adv Alcohol Subst Abuse; 1983-1984 Fall-Winter; 3(1-2):53-73. PubMed ID: 6391103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine and psychiatric symptoms: a review.
    Broderick P; Benjamin AB
    J Okla State Med Assoc; 2004 Dec; 97(12):538-42. PubMed ID: 15732884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding.
    Kaplan GB; Greenblatt DJ; Kent MA; Cotreau-Bibbo MM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1563-72. PubMed ID: 8371158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mountain Dew or mountain don't?: a pilot investigation of caffeine use parameters and relations to depression and anxiety symptoms in 5th- and 10th-grade students.
    Luebbe AM; Bell DJ
    J Sch Health; 2009 Aug; 79(8):380-7. PubMed ID: 19630872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of caffeine in volunteers with different patterns of regular consumption.
    Hewlett P; Smith A
    Hum Psychopharmacol; 2006 Apr; 21(3):167-80. PubMed ID: 16521153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine challenge test in panic disorder and depression with panic attacks.
    Nardi AE; Lopes FL; Valença AM; Freire RC; Veras AB; de-Melo-Neto VL; Nascimento I; King AL; Mezzasalma MA; Soares-Filho GL; Zin WA
    Compr Psychiatry; 2007; 48(3):257-63. PubMed ID: 17445520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anxiety and depression caused by side effects of drugs].
    Nijdam S
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(4):51-3. PubMed ID: 2167587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anxiogenic effects of caffeine.
    Bruce MS
    Postgrad Med J; 1990; 66 Suppl 2():S18-24. PubMed ID: 2392393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement.
    Griffiths RR; Chausmer AL
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Nov; 20(5):223-31. PubMed ID: 11326548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychostimulant and other effects of caffeine in 9- to 11-year-old children.
    Heatherley SV; Hancock KM; Rogers PJ
    J Child Psychol Psychiatry; 2006 Feb; 47(2):135-42. PubMed ID: 16423144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine withdrawal: a parametric analysis of caffeine dosing conditions.
    Evans SM; Griffiths RR
    J Pharmacol Exp Ther; 1999 Apr; 289(1):285-94. PubMed ID: 10087016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.